View the Zacks #1 Rank List
View All Zacks #1 Ranked StocksVRDN 17.90 +0.51(2.93%)
Will VRDN be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for VRDN based on the 1-3 month trading system that more than doubles the S&P 500.
-
MU
Micron Technology
-
#1
-
AAPL
Apple
-
#2
-
NVDA
NVIDIA
-
#3
-
PLTR
Palantir Technologies
-
#4
-
SPCX
Space Exploration Technologies Corp.
-
#5
-
SNDK
Sandisk Corporation
-
#6
-
AVGO
Broadcom
-
#7
Zacks News for VRDN
AMGN's Subcutaneous Tepezza Scores Phase III Win in Thyroid Eye Disease
Viridian Therapeutics (VRDN) Soars 5.6%: Is Further Upside Left in the Stock?
VRDN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Viridian Therapeutics, Inc. (VRDN) Reports Q4 Loss, Misses Revenue Estimates
MiMedx (MDXG) Q4 Earnings and Revenues Beat Estimates
Viridian Therapeutics, Inc. (VRDN) Reports Q3 Loss, Tops Revenue Estimates
Other News for VRDN
Analysts Are Bullish on These Healthcare Stocks: Viridian Therapeutics (VRDN), Genfleet Therapeutics (Shanghai), Inc. Class H (HK:2595)
Viridian Therapeutics (VRDN) Launches Lumvoa Following FDA Approval
Viridian launches first commercial product as U.S. approves thyroid eye disease therapy
VRDN rises 2.93% on June 26, leaving the technical picture intact
VRDN's price rises by 2.65% on June 26, though its technical setup remains stable.